289 related articles for article (PubMed ID: 7884589)
1. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
Sallinen PK; Haapasalo HK; Visakorpi T; Helén PT; Rantala IS; Isola JJ; Helin HJ
J Pathol; 1994 Dec; 174(4):275-82. PubMed ID: 7884589
[TBL] [Abstract][Full Text] [Related]
2. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms.
Haapasalo HK; Sallinen PK; Helén PT; Rantala IS; Helin HJ; Isola JJ
J Pathol; 1993 Nov; 171(3):207-14. PubMed ID: 7903983
[TBL] [Abstract][Full Text] [Related]
4. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
[TBL] [Abstract][Full Text] [Related]
5. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
6. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
7. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
[TBL] [Abstract][Full Text] [Related]
10. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma.
Visakorpi T
J Pathol; 1992 Sep; 168(1):7-13. PubMed ID: 1360498
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.
McKeever PE; Ross DA; Strawderman MS; Brunberg JA; Greenberg HS; Junck L
J Neuropathol Exp Neurol; 1997 Jul; 56(7):798-805. PubMed ID: 9210876
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
13. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Veronese SM; Maisano C; Scibilia J
Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
[TBL] [Abstract][Full Text] [Related]
14. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
[TBL] [Abstract][Full Text] [Related]
15. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections.
Skalova A; Leivo I; Von Boguslawsky K; Saksela E
J Pathol; 1994 May; 173(1):13-21. PubMed ID: 7931834
[TBL] [Abstract][Full Text] [Related]
16. Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.
MacGrogan G; Jollet I; Huet S; Sierankowski G; Picot V; Bonichon F; Coindre JM
Mod Pathol; 1997 Aug; 10(8):769-76. PubMed ID: 9267818
[TBL] [Abstract][Full Text] [Related]
17. A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers.
Gee JM; Douglas-Jones A; Hepburn P; Sharma AK; McClelland RA; Ellis IO; Nicholson RI
J Pathol; 1995 Nov; 177(3):285-93. PubMed ID: 8551391
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.
Kros JM; Hop WC; Godschalk JJ; Krishnadath KK
Cancer; 1996 Sep; 78(5):1107-13. PubMed ID: 8780550
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of MIB-1 in neuroendocrine tumours of the lung.
Böhm J; Koch S; Gais P; Jütting U; Präuer HW; Höfler H
J Pathol; 1996 Apr; 178(4):402-9. PubMed ID: 8691318
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors.
Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ
Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]